Abstract:As advances in high-resolution single-cell technology shed light on the complex microenvironment of tumors, the focus of clinical strategies has shifted to single-cell phenotypes in stratified subgroups, and targeting tumor immune-associated landscape strategies may enable more precise treatment modalities. With the elucidation of the tumor landscape, immunotherapy has taken off, but its effectiveness has been hampered by immune escape and the resulting immunological-related side effects. As a result, immunotherapy is invariably studied in concert with other therapies in order to safely and effectively stimulate the anticancer immunity. Photodynamic therapy is unsurpassed in filling gaps in current cancer immunotherapy due to its direct cytotoxic effects, tumor vascular system damage, and generation of a powerful immune response. The mutually reinforcing effects of photodynamic therapy and the tumor-associated immune landscape have been well researched over the years, suggesting that photodynamic therapy combined with targeting tumor landscape strategies can become “magic bullet” in antitumor therapy. However, the inability of conventional drug administration to penetrate malignant tissue and the toxicity of normal tissue owing to passive diffusion have limited their clinical application. Delivery systems based on multifunctional nanomaterials with precise controlled drug release can synergize with other therapies, acting as a bridge to photodynamic immunotherapy. The first thorough and current review of PDT synergistic targeting of tumor-associated immune landscapes employing nanomaterials as bridges is provided in this article. The synergistic therapeutic molecular mechanisms of these nanomaterials, as well as the accompanying design methodologies, are elaborated by following the concept of “from bench to clinic”, covering the latest advanced applications of these nanomaterials, issues in clinical translation, and the outlook.

Anion receptor-mediated multicomponent synergistic self-assembly of porphyrin for efficient phototherapy to elicit tumor immunotherapy

Biocompatible conjugated porphyrin nanoparticles with photodynamic/photothermal performances in cancer therapy

Nanoplatform Self‐Assembly from Small Molecules of Porphyrin Derivatives for NIR‐II Fluorescence Imaging Guided Photothermal‐Immunotherapy

Targeted nanocarriers based on iodinated-cyanine dyes as immunomodulators for synergistic phototherapy

Self-assembled nanospheres mediate phototherapy and deliver CpG oligodeoxynucleotides to enhance cancer immunotherapy of breast cancer and melanoma

Activating Antitumor Immunity and Antimetastatic Effect Through Polydopamine-Encapsulated Core-Shell Upconversion Nanoparticles

A Cu 9 S 5 nanoparticle-based CpG delivery system for synergistic photothermal-, photodynamic- and immunotherapy

A photo-triggered self-accelerated nanoplatform for multifunctional image-guided combination cancer immunotherapy

Autophagy activator-loaded bicomponent peptide nanocarriers for phototherapy-triggered immunity enhancement against metastatic breast cancer

Biomimetic Nanomodulators With Synergism of Photothermal Therapy and Vessel Normalization for Boosting Potent Anticancer Immunity

Multifunctional Nanoparticles-Mediated PTT/PDT Synergistic Immune Activation and Antitumor Activity Combined with Anti-PD-L1 Immunotherapy for Breast Cancer Treatment

Self-Adjuvanting Photosensitizer Nanoparticles For Combination Photodynamic Immunotherapy

Mitochondria-Targeting and Multiresponsive Nanoplatform Based on AIEgens for Synergistic Chemo-Photodynamic Therapy and Enhanced Immunotherapy.

Advanced Nanoplatform Mediated by CRISPR-Cas9 and Aggregation-Induced Emission Photosensitizers to Boost Cancer Theranostics

Type I photodynamic therapy with a self-degradable conjugated polyelectrolyte in combination with CpG adjuvant for cancer immunotherapy

Molecularly engineered carrier-free co-delivery nanoassembly for self-sensitized photothermal cancer therapy

Drug-drug conjugates self-assembled nanomedicines triggered photo-/immuno- therapy for synergistic cancer treatments

Enhancing tumor immunotherapy via photodynamic therapy with a cascade reaction of reactive oxygen species and sustaining nutrient supply

Task-Specific Design of Immune-Augmented Nanoplatform to Enable High-Efficiency Tumor Immunotherapy

Harnessing Dual Phototherapy and Immune Activation for Cancer Treatment: the Development and Application of BODIPY@F127 Nanoparticles.

Visualized Photodynamic Nanomaterials Activating Tumor-Associated Immune Landscape As a Next-Generation Anticancer Strategy